Evolving role of viadisc for chronic low back and discogenic pain: a narrative review

IF 2.7 3区医学 Q2 PHARMACOLOGY & PHARMACY

Expert Opinion on Emerging Drugs Pub Date : 2024-04-11 DOI:10.1080/14728214.2024.2339912

Jack K. Tolson, Robert L. Menuet, Gianni H. Ly, Benjamin A. Chanes, Elizabeth A. Bryan, Saurabh Kataria, Julian Kim, Shahab Ahmadzadeh, Sahar Shekoohi, Alan D. Kaye

引用次数: 0

Abstract

Chronic lower back pain is a leading cause of disability and healthcare spending worldwide. Discogenic pain, pain originating from the intervertebral disk, is a common etiology of chronic lower bac...

查看原文本刊更多论文

viadisc 在治疗慢性腰痛和椎间盘源性疼痛方面不断演变的作用：叙述性综述

慢性下背痛是导致全球残疾和医疗支出的主要原因。椎间盘源性疼痛，即源自椎间盘的疼痛，是慢性下背痛的常见病因。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Expert Opinion on Emerging Drugs 医学-药学

CiteScore

5.90

自引率

0.00%

发文量

审稿时长

>12 weeks

期刊介绍： Expert Opinion on Emerging Drugs (ISSN 1472-8214 [print], 1744-7623 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing structured reviews on Phase II and Phase III drugs/drug classes emerging onto the market across all therapy areas, providing expert opinion on their potential impact on the current management of specific diseases.